HighVista Strategies »

Rxo shares owned by HighVista Strategies

Quarter-by-quarter ownership of Rxo (RXO) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Rxo

Tip: Access up to 7 years of quarterly data

All positions including Rxo held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxo by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2023-09-30 $803k 41k 19.73
2023-06-30 $757k 33k 22.67

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Activision Blizzard
Vmware Cl A Com
Albertsons Cos Common Stock (ACI)
Immunovant (IMVT)
Capri Holdings SHS (CPRI)
Horizon Therapeutics Pub L SHS
stock
Seagen
Axsome Therapeutics (AXSM)
Structure Therapeutics Sponsored Ads (GPCR)
Amedisys (AMED)
Ideaya Biosciences (IDYA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Microsoft Corporation (MSFT)

View all positions for HighVista Strategies

Top funds holding Rxo

Orbis Allan Gray
Vanguard Group
Douglas Lane & Associates
Dimensional Fund Advisors
Charles Schwab Investment Management
Wellington Management Company
Massachusetts Financial Services
Fred Alger Management
Jacobs Levy Equity Management
Norges Bank Investment Management
Divisar Capital Management
Bank of New York Mellon
PRIMECAP Management Company
Boundary Creek Advisors
Motley Fool Wealth Management

View all funds holding Rxo